NAUT
Nautilus Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.90
−2.62%Leverage
- Debt / equity
- 0.21x
- Net debt / equity
- 0.11x
- Debt / assets
- 0.17x
- Debt / EBITDA
- -0.51x
- Net debt / EBITDA
- -0.27x
Liquidity & coverage
- Current ratio
- 10.14x
- Quick ratio
- 10.14x
- Cash ratio
- 9.73x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $79.0M
Cash & dividend
- FCF / debt
- -1.86x
- Cash flow / debt
- -1.81x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026